Home2025August13Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease – Novartis Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease – Novartis August 13, 2025betadmin None #stockmarket #breaking
Starbucks CEO Brian Niccol announces plans for corporate layoffs – KING5.com $SBUX Starbucks said Friday it plans an unspecified number of layoffs as it restructures its corporate staff. #stockmarket #breaking
Man arrested after allegedly sneaking onto United Airlines flight with fake boarding pass – NBC News $AAL A man was arrested after allegedly sneaking onto a United Airlines flight with a fake boarding pass at Houston’s George…
The 4 ‘fatal flaws’ in Tesla’s bid to award Elon Musk $100 billion, according to the judge who dashed his pay – Fortune $TSLA #Tesla Defendants who lose at trial can’t just “hit reset” with a new stockholder vote, the chancellor concluded. #stockmarket #breaking